Advanced Hematology Diagnostics: Expect Accuracy and Efficiency with Precipio

Precipio creates proprietary hematology diagnostic products that help laboratories achieve faster and more efficient throughput, improve their economics, and most importantly, deliver superior diagnostic accuracy to patients and physicians.

View Products View Services

Expect More

Precipio creates proprietary hematology diagnostic products that help laboratories achieve faster and more efficient throughput, improve their economics, and most importantly, deliver superior diagnostic accuracy to patients and physicians.

View Products View Services

HemeScreen Reagents

Cutting edge molecular testing technology, with simplified workflow and attractive economics

IV-Cell Culture Media

Multi-cell lineage culturing media, delivering simplified workflow and unparalleled clinical accuracy

Clinical Services

Hematopathology diagnostic services at the highest level of accuracy, quality, and service

Clinical Hematology Lab Services

We deliver superior hematology diagnostic accuracy to patients and physicians

We do this by capturing insights from our cancer diagnostics clinical laboratory, selecting our best technologies to commercialize into products, and selling them through a network of global distribution partners.

Expect More

Clinical Hematology Diagnostics at the Highest Level
of Accuracy, Quality, and Service

1 in 4 blood cancer patients is misdiagnosed. We get it right from the start through cutting-edge technology and unparalleled expertise.

Learn More

We develop proprietary technologies to meet the diagnostic needs of personalized medicine with faster turn around times.

Learn More

A second opinion from a world-class specialized expert provides patients & physicians peace of mind that their treatment plan is on the right track.

Learn More

Our Culture

Precipio’s culture is one of care. The company exists to battle a problem that affects hundreds of thousands of patients, and their families, each year. Every patient that is impacted by the work we do, is treated with the same care we would treat our own family.

Hands together

Innovative Technology

View Hematology Lab Products

BloodhoundTM BCR-ABL1

HemeScreen® AML

BloodhoundTM ABL1 Resistance

HemeScreen® Cytopenia

BloodhoundTM MPN

HemeScreen® CLL

HemeScreen® MPN

IV-Cell™ Cytogenetics Culture Medium

The Latest at Precipio

News & Events

Precipio Announces Year end 2023 Shareholder Update Call

Conference Call to be held on April 1st, 2024 at 5:00 PM EST NEW HAVEN, [...]

Read More
Precipio to Report $15.2M for FY-2023 (unaudited) Revenues, an increase of 60% YoY

Company continues to make strides towards breakeven NEW HAVEN, CT, Globenewswire – (February 13, 2024) – [...]

Read More
Precipio and Cardinal Health Sign Distribution Agreement for its HemeScreen® Portfolio of Molecular assays for Cancer

NEW HAVEN, CT, Globenewswire – (February 6, 2024) – Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: [...]

Read More

Stay up to date on the latest news and information.
Sign up for our newsletter